Back to search

Effect of HMG-CoA reductase inhibitors on plasma polyunsaturated fatty acid concentrations in patients with hyperlipidemia

Data up to Jan 2025

Published1998
Citations44
References17

Total Citations Per Year

Abstract

References (17)

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1994 • 8,631 citations

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

1995 • 7,378 citations

Regulation of the mevalonate pathway

1990 • 5,282 citations

PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

1995 • 3,524 citations

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

1975 • 3,075 citations

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

1983 • 2,839 citations

EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART)

1989 • 2,639 citations

Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B

1990 • 2,192 citations

Dietary Intake and Cell Membrane Levels of Long-Chain n-3 Polyunsaturated Fatty Acids and the Risk of Primary Cardiac Arrest

1995 • 911 citations

Modulation of membrane function by cholesterol

1991 • 344 citations

Increased arachidonate in lipids after administration to man: Effects on prostaglandin biosynthesis

1975 • 163 citations

Low phospholipid arachidonic acid values in diabetic platelets.

1983 • 90 citations

Lovastatin increases arachidonic acid levels and stimulates thromboxane synthesis in human liver and monocytic cell lines.

1994 • 41 citations

Short-term diabetic ketosis alters n-6 polyunsaturated fatty acid content in plasma phospholipids.

1996 • 27 citations

Effects of eicosapentaenoic acids on remnant-like particles, cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus.

1998 • 23 citations

Reduction of LDL cholesterol by pravastatin does not influence platelet activation in patients with mild hypercholesterolaemia at risk of coronary heart disease.

1991 • 16 citations

Effets of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia

1995 • 12 citations

Cited By (0)

Loading...